Sci-Engi-Medco Solutions Inc. Announces PLOS Publication of a Novel Mechanism of Action for Its AAAPT Technology Expanding the Therapeutic Index of Difficult to Treat Cancers

ST. CHARLES, Mo., March 4, 2021 /PRNewswire/ -- On this Triple Negative Breast Cancer awareness day, Sci-Engi-Medco Solutions Inc. (SEMCO), a private cancer drug discovery and development company that explores its proprietary small molecule targeted anticancer agent tumor sensitizing...

from PR Newswire: https://ift.tt/2OpqYDY